Overview

C4U is a biotechnology venture company from Osaka University, engaging in research and development of novel genome editing technology, CRISPR-Cas3. Utilizing newly invented cutting-edge genome editing technology, C4U promotes the development of new treatments for various diseases, including genetic diseases. C4U also collaborates with other companies and is working to develop platforms for applications in other industries.